• Direct Mouse Genotyping Kit Plus: Precision in Mouse Genotyp

  2026-07-10

  The Direct Mouse Genotyping Kit Plus streamlines mouse genotyping with rapid, purification-free DNA extraction and high-fidelity PCR, ideal for transgene detection and gene knockout validation. Its robust workflow accelerates animal colony genetic screening and delivers reproducible results, even with challenging tissue samples.

• High Viscosity Drives Chemoresistance via P-gp Upregulation

  2026-07-09

  This study reveals that increased extracellular fluid viscosity in the tumor microenvironment induces chemoresistance by upregulating P-glycoprotein (P-gp) expression through a mechanosensitive signaling axis. These findings highlight the biomechanical regulation of drug resistance and suggest that targeting microenvironmental viscosity or P-gp may enhance chemotherapy outcomes.

• PFHxS Disrupts Lipid Metabolism via PPARα Activation in Zebr

  2026-07-09

  This study uncovers how environmentally relevant levels of perfluorohexanesulfonic acid (PFHxS) disrupt lipid homeostasis in zebrafish larvae through targeted activation of PPARα signaling. Integrated lipidomic and transcriptomic approaches reveal molecular pathways affected by PFHxS, highlighting its significance for metabolic disorder research and toxicological risk assessment.

• Technical Use and QC of 0.4% Trypan Blue Solution (K1183)

  2026-07-08

  0.4% Trypan Blue Solution provides a fast, reliable approach for assessing cell viability and live/dead discrimination in research cell culture workflows. It should be used for membrane-integrity–based viability checks, but is not appropriate for clinical diagnostics or for detecting early apoptotic changes. Researchers should follow established QC protocols to ensure accurate, reproducible results.

• Arachidonic Acid: Optimizing Eicosanoid Biosynthesis Assays

  2026-07-08

  Arachidonic acid unlocks precise control in inflammation and immune cell assays, bridging basic lipid signaling models to translational vaccine research. Its solubility profile, bioactivity, and validated impact on humoral immunity make it indispensable for advanced eicosanoid biosynthesis workflows.

• Gap26 Connexin 43 Mimetic Peptide: Advanced Insights in Infl

  2026-07-07

  Explore the scientific depth of Gap26, a connexin 43 mimetic peptide, in modulating inflammation and vascular signaling. This article uniquely analyzes mechanistic findings and assay decision-making, offering advanced context beyond existing resources.

• CCK-8 Ammonium Induces ANP Secretion via NOX4–PGC-1α–PPAR Pa

  2026-07-07

  This study demonstrates how sulfated cholecystokinin octapeptide (CCK-8 ammonium) directly stimulates atrial natriuretic peptide (ANP) secretion in isolated rat atria via a defined NOX4–PGC-1α–PPARα/PPARγ signaling axis. The findings clarify the cardiac signaling mechanisms of CCK-8 and suggest new avenues for investigating peptide-mediated regulation of cardiovascular function.

• ZCL278: Selective Cdc42 Inhibitor for Cell Motility and Fibr

  2026-07-06

  ZCL278 empowers targeted dissection of the Cdc42 signaling pathway, enabling researchers to modulate cell motility, neuronal branching, and fibrotic responses with unprecedented precision. This guide delivers actionable protocols, advanced troubleshooting, and translational insights, positioning ZCL278 as a uniquely versatile tool for mechanistic and disease modeling studies.

• Applied Use of 2',7'-Dichlorofluorescein Diacetate for ROS D

  2026-07-06

  2',7'-Dichlorofluorescein diacetate enables sensitive and versatile intracellular ROS measurement, streamlining workflows across oncology, toxicology, and drug discovery. This article delivers protocol enhancements, troubleshooting insights, and strategic context from recent nanocarrier studies, empowering researchers to maximize redox assay reliability.

• Ellagic Acid: Selective CK2 Inhibitor for Cancer Biology Res

  2026-07-05

  Ellagic acid is a selective, ATP-competitive inhibitor of casein kinase 2 (CK2) with nanomolar potency. This compound, provided by APExBIO, is a precise tool for dissecting CK2-related signaling pathways in cancer biology and oxidative stress assays. Its specificity, solubility profile, and evidence-backed applications make it valuable for apoptosis and senescence research.

• Refining In Vitro Cancer Drug Evaluation: Lessons from Schwa

  2026-07-04

  Schwartz (2022) critically examined how in vitro assays measure anti-cancer drug responses, distinguishing between proliferative arrest and cell death. The work clarifies that most drugs modulate both processes, but in varying proportions and timing, emphasizing the need for more precise assay interpretation in research and preclinical development.

• Universal nPEC Method for Dual-Loaded Liposome Encapsulation

  2026-07-03

  This study introduces and validates a nanoparticle exclusion chromatography (nPEC) method for accurately and efficiently determining the encapsulation efficiency of both hydrophilic and lipophilic drugs in dual-loaded liposomes. The findings support more robust assessment of advanced drug delivery systems, providing a scalable solution for researchers working with complex combinations, including those involving immune-modulatory compounds.

• CHIR-99021 (CT99021): Reproducibility in Stem Cell & Viabili

  2026-07-03

  This article explores real-world laboratory scenarios where CHIR-99021 (CT99021), SKU A3011, delivers reproducible, literature-backed solutions for cell viability, proliferation, and differentiation workflows. Using scenario-driven Q&A, we address protocol optimization, data interpretation, and product selection for biomedical researchers. Discover how this selective GSK-3 inhibitor advances assay reliability and workflow efficiency.

• Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301) Gu

  2026-07-02

  Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301) enable high-specificity capture and purification of biotinylated molecules from complex samples, addressing challenges in workflows such as immunoprecipitation and protein interaction studies. These beads are not suited for applications where hydrophobic interactions would compromise target integrity or specificity.

• LLY507: Precision SMYD2 Inhibition for Epigenetic Cancer Res

  2026-07-02

  Explore how LLY507, a potent SMYD2 inhibitor, enables precise modulation of lysine methylation in cancer and kidney fibrosis research. This article offers an advanced, evidence-driven analysis with unique protocol insights and assay guidance.

454 records 12/31 page Previous Next First page 上5页 1112131415 下5页 Last page